These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2474101)

  • 21. Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
    Vierhapper H; Witte PU; Waldhäusl W
    J Hypertens; 1986 Feb; 4(1):9-11. PubMed ID: 3007605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.
    Manhem PJ; Ball SG; Morton JJ; Murray GD; Leckie BJ; Fraser R; Robertson JI
    Br J Clin Pharmacol; 1985 Jul; 20(1):27-35. PubMed ID: 2992562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril.
    Stevens BR; Fernandez A; Kneer C; Cerda JJ; Phillips MI; Woodward ER
    Gastroenterology; 1988 Apr; 94(4):942-7. PubMed ID: 2831105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
    Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
    Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
    Webb DJ; Collier JG
    Am J Cardiol; 1987 Apr; 59(10):45D-49D. PubMed ID: 2953225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
    Clauser E
    Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function.
    Tillman DM; Adams FG; Gillen G; Morton JJ; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):133D-142D. PubMed ID: 3034022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats.
    Gould AB; Goodman SA
    Eur J Pharmacol; 1990 Jun; 181(3):225-34. PubMed ID: 2143478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.
    Thuillez C; Richer C; Giudicelli JF
    Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic nervous activity and noradrenaline reactivity during angiotensin converting enzyme inhibition.
    Philipp T; Sharma AM; Thiede HM; Kribben A
    Am J Cardiol; 1987 Apr; 59(10):55D-59D. PubMed ID: 3034034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency.
    Schunkert H; Kindler J; Gassmann M; Lahn W; Irmisch R; Ritz E; Debusmann ER; Pujadas JO; Koch KM; Sieberth HG
    Eur J Clin Pharmacol; 1989; 37(3):249-56. PubMed ID: 2533075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ramipril inhibition of rabbit (Oryctolagus cuniculus) small intestinal brush border membrane angiotensin converting enzyme.
    Stevens BR; Phillips MI; Fernandez A
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 91(2):493-7. PubMed ID: 2905962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure.
    Vogt A; Unterberg C; Kreuzer H
    Am J Cardiol; 1987 Apr; 59(10):149D-154D. PubMed ID: 3034024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic effects of ramipril and captopril in congestive heart failure.
    de Graeff PA; Kingma JH; Viersma JW; Wesseling H; Lie KI
    Int J Cardiol; 1989 Apr; 23(1):59-67. PubMed ID: 2523870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of renal prostaglandins in the action of ramipril (HOE-498) in normotensive rats.
    Lahera V; Durán F; Cachofeiro V; Cañizo FJ; Cantón JJ; Rodriguez FJ; Tresguerres JA
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jan; 35(1):25-30. PubMed ID: 2522661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.